Context: For health care planning and allocation of resources, realistic estimation of the
prevalence of primary aldosteronism is necessary. Reported prevalences of primary …

There is an ongoing controversy on the prevalence of primary aldosteronism (PA). We
aimed to update a meta-analysis published in 2008, that compiled studies reporting the …

BACKGROUND: Antihypertensive and tissue-protective properties of vitamin D metabolites
are increasingly attributed to the inhibition of renin synthesis by 1, 25-dihydroxyvitamin D [1 …

Secondary diabetes mellitus is frequently ignored in specialized literature. In this narrative
review, the main endocrinopathies accompanied by increased glycemic values are …

Inappropriate aldosterone and parathyroid hormone (PTH) secretion is strongly linked with
development and progression of cardiovascular (CV) disease. Accumulating evidence …

Hypertension is defined as a persistently elevated blood pressure≥ 140/90 mm Hg. It is an
important treatable risk factor for cardiovascular disease, with a high prevalence in the …

Animal and human studies support a clinically relevant interaction between aldosterone and
parathyroid hormone (PTH) levels and suggest an impact of the interaction on …

In 1953 an American endocrinologist by the name of Jerome W. Conn 1 described a young
female patient who presented with a syndrome of intermittent muscle spasms, weakness …

Introduction: Concentrations of 1, 25-hydroxyvitamin D have been positively associated with
dietary sodium and salt sensitivity (SS) of blood pressure (BP), and inversely with plasma …

Aims Cardiac remodelling might be an important mechanism for aldosterone-mediated
cardiovascular (CV) morbidity and mortality. Previous studies relating aldosterone to left …